clinicaltrialsarena3h
Eirion sees success in ‘first-in-man’ topical hair-loss therapy trial
The company says the early trial of its hair-loss therapy saw patients benefit from six times more hair growth than placebo.
clinicaltrialsarena3h
Insilico announces positive results from Phase I trials of AI-designed ISM5411
ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.
clinicaltrialsarena6h
Ryght AI and QPS to optimise global clinical trial processes
Ryght AI has announced a strategic collaboration with QPS Holdings for optimising clinical trial processes globally.
clinicaltrialsarena6h
Early success for MBX in Phase I trial of GLP-1RA for hypoglycaemia
RA was well tolerated in the Phase I trial. Now MBX is planning a Phase II trial in post-bariatric hypoglycaemia patients.
clinicaltrialsarena10h
J&J reports positive topline outcomes from Phase III NSCLC combo therapy trial
J&J has reported positive topline outcomes from the MARIPOSA trial of RYBREVANT and LAZCLUZE combo for NSCLC treatment.
clinicaltrialsarena11h
BIAL’s first subject completes full dose regimen in Parkinson’s treatment trial
BIAL has completed the full dose regimen for the first subject in the Phase II ACTIVATE trial of BIA 28-6156, for Parkinson's treatment.